Skip to content

Clinical trials

Phase 2/3 Thalassemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Phase: Phase 2/3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20092
20141
20182
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aga Khan University1
Blood Diseases Clinic1
Carelon Research1
Masonic Cancer Center, University of Minnesota1
Mazandaran University of Medical Sciences1
Tehran University of Medical Sciences1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia7
beta-Thalassemia2
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Genetic Diseases, Inborn1
Hematologic Diseases1
Hemoglobinopathies1
Hypertension, Pulmonary1
Shwachman-Diamond Syndrome1

Trials

Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.